Exercise Intolerance in Heart Failure: Did We Forget the Brain?

Canadian Journal of Cardiology

Volumn 32, Issue 4, 2016, Pages 475-484

  Brassard, Patrice ^a,b   Gustafsson, Finn ^c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC EXERCISE; BRAIN BLOOD FLOW; COMORBIDITY; EXERCISE; EXERCISE INTENSITY; EXERCISE TOLERANCE; HEART FAILURE; HUMAN; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; REVIEW; BRAIN; BRAIN CIRCULATION; EXERCISE TEST; PHYSIOLOGY;

BRAIN; CEREBROVASCULAR CIRCULATION; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HUMANS;

EID: 84961782127     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.12.021     Document Type: Review

References (137)

1. Cohen-Solal A., Logeart D., Guiti C., Dahan M., Gourgon R. Cardiac and peripheral responses to exercise in patients with chronic heart failure. Eur Heart J 1999, 20:931-945.
2. Kim Y.S., Seifert T., Brassard P., et al. Impaired cerebral blood flow and oxygenation during exercise in type 2 diabetic patients. Physiol Rep 2015, 3:e12430.
3. Fu T.C., Wang C.H., Hsu C.C., et al. Suppression of cerebral hemodynamics is associated with reduced functional capacity in patients with heart failure. Am J Physiol Heart Circ Physiol 2011, 300:H1545-H1555.
4. Zelis R., Sinoway L.I., Musch T.I., Davis D., Just H. Regional blood flow in congestive heart failure: concept of compensatory mechanisms with short and long time constants. Am J Cardiol 1988, 62:2E-8E.
5. Saxena P.R., Schoemaker R.G. Organ blood flow protection in hypertension and congestive heart failure. Am J Med 1993, 94:4S-12S.
6. Gruhn N., Larsen F.S., Boesgaard S., et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001, 32:2530-2533.
7. Vogels R.L., Oosterman J.M., Laman D.M., et al. Transcranial Doppler blood flow assessment in patients with mild heart failure: correlates with neuroimaging and cognitive performance. Congest Heart Fail 2008, 14:61-65.
8. Fraser K.S., Heckman G.A., McKelvie R.S., et al. Cerebral hypoperfusion is exaggerated with an upright posture in heart failure: impact of depressed cardiac output. JACC Heart Fail 2015, 3:168-175.
9. Choi B.R., Kim J.S., Yang Y.J., et al. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2006, 97:1365-1369.
10. Wanless R.B., Anand I.S., Gurden J., Harris P., Poole-Wilson P.A. Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther 1987, 243:1101-1106.
11. Aggarwal A., Esler M.D., Lambert G.W., et al. Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure. Circulation 2002, 105:1031-1033.
12. Francis G.S. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J 1989, 118:642-648.
13. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992, 20:248-254.
14. Birdsill A.C., Carlsson C.M., Willette A.A., et al. Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity 2013, 21:1313-1320.
15. Yadav S.K., Kumar R., Macey P.M., et al. Regional cerebral blood flow alterations in obstructive sleep apnea. Neurosci Lett 2013, 555:159-164.
16. Novak V., Last D., Alsop D.C., et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 2006, 29:1529-1534.
17. Fujishima M., Ibayashi S., Fujii Y., Mori S. Cerebral blood flow and brain function in hypertension. Hypertens Res 1995, 18:7.
18. Alosco M.L., Spitznagel M.B., Sweet L.H., et al. Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure. Pacing Clin Electrophysiol 2015, 38:178-186.
19. Higginbotham M.B., Morris K.G., Williams R.S., et al. Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res 1986, 58:281-291.
20. Zavorsky G.S. Evidence and possible mechanisms of altered maximum heart rate with endurance training and tapering. Sports Med 2000, 29:13-26.
21. Andersen P., Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol 1985, 366:233-249.
22. Blomqvist C.G., Saltin B. Cardiovascular adaptations to physical training. Annu Rev Physiol 1983, 45:169-189.
23. Holloszy J.O., Coyle E.F. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol Respir Environ Exerc Physiol 1984, 56:831-838.
24. Florea V.G., Mareyev V.Y., Achilov A.A., et al. Central and peripheral components of chronic heart failure: determinants of exercise tolerance. Int J Cardiol 1999, 70:51-56.
25. Cooke G.A., Marshall P., al-Timman J.K., et al. Physiological cardiac reserve: development of a non-invasive method and first estimates in man. Heart 1998, 79:289-294.
26. Lele S.S., Macfarlane D., Morrison S., et al. Determinants of exercise capacity in patients with coronary artery disease and mild to moderate systolic dysfunction. Role of heart rate and diastolic filling abnormalities. Eur Heart J 1996, 17:204-212.
27. Sullivan M.J., Knight J.D., Higginbotham M.B., Cobb F.R. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989, 80:769-781.
28. Fortin M., Turgeon P.Y., Nadreau E., et al. Prognostic value of oxygen kinetics during recovery from cardiopulmonary exercise testing in patients with chronic heart failure. Can J Cardiol 2015, 31:1259-1265.
29. Francis G.S., Goldsmith S.R., Cohn J.N. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J 1982, 104:725-731.
30. Di Salvo T.G., Mathier M., Semigran M.J., Dec G.W. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995, 25:1143-1153.
31. Hummel Y.M., Bugatti S., Damman K., et al. Functional and hemodynamic cardiac determinants of exercise capacity in patients with systolic heart failure. Am J Cardiol 2012, 110:1336-1341.
32. Clark A.L., Swan J.W., Laney R., et al. The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure. Circulation 1994, 89:2062-2069.
33. Haykowsky M.J., Brubaker P.H., John J.M., et al. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol 2011, 58:265-274.
34. Kitzman D.W., Little W.C., Brubaker P.H., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002, 288:2144-2150.
35. Borlaug B.A., Melenovsky V., Russell S.D., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114:2138-2147.
36. Borlaug B.A., Nishimura R.A., Sorajja P., Lam C.S., Redfield M.M. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3:588-595.
37. Andersen M.J., Ersboll M., Bro-Jeppesen J., et al. Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction. Circ Heart Fail 2012, 5:444-451.
38. Maeder M.T., Thompson B.R., Htun N., Kaye D.M. Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fraction. J Cardiac Fail 2012, 18:702-710.
39. Borlaug B.A., Olson T.P., Lam C.S., et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010, 56:845-854.
40. Clark A.L., Davies L.C., Francis D.P., Coats A.J. Ventilatory capacity and exercise tolerance in patients with chronic stable heart failure. Eur J Heart Fail 2000, 2:47-51.
41. Wasserman K., Zhang Y.Y., Gitt A., et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997, 96:2221-2227.
42. Narkiewicz K., Pesek C.A., van de Borne P.J., Kato M., Somers V.K. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999, 100:262-267.
43. Esposito F., Mathieu-Costello O., Shabetai R., Wagner P.D., Richardson R.S. Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors. J Am Coll Cardiol 2010, 55:1945-1954.
44. Middlekauff H.R. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 2010, 3:537-546.
45. Cicoira M., Zanolla L., Franceschini L., et al. Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol 2001, 37:2080-2085.
46. Piepoli M.F., Guazzi M., Boriani G., et al. Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II. Eur J Cardiovasc Prev Rehabil 2010, 17:643-648.
47. Notarius C.F., Millar P.J., Murai H., et al. Divergent muscle sympathetic responses to dynamic leg exercise in heart failure and age-matched healthy subjects. J Physiol 2015, 593:715-722.
48. De Sousa E., Veksler V., Bigard X., Mateo P., Ventura-Clapier R. Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation 2000, 102:1847-1853.
49. Harrington D., Anker S.D., Chua T.P., et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997, 30:1758-1764.
50. Drexler H., Riede U., Munzel T., et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992, 85:1751-1759.
51. Brassard P., Maltais F., Noel M., et al. Skeletal muscle endurance and muscle metabolism in patients with chronic heart failure. Can J Cardiol 2006, 22:387-392.
52. Jonsdottir S., Andersen K.K., Sigurosson A.F., Sigurosson S.B. The effect of physical training in chronic heart failure. Eur J Heart Fail 2006, 8:97-101.
53. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002, 39:1780-1786.
54. Duke M., Abelmann W.H. The hemodynamic response to chronic anemia. Circulation 1969, 39:503-515.
55. Varat M.A., Adolph R.J., Fowler N.O. Cardiovascular effects of anemia. Am Heart J 1972, 83:415-426.
56. Mancini D.M., Kunavarapu C. Effect of erythropoietin on exercise capacity in anemic patients with advanced heart failure. Kidney Int Suppl 2003, S48-S52.
57. Okonko D.O., Mandal A.K., Missouris C.G., Poole-Wilson P.A. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 2011, 58:1241-1251.
58. Mentz R.J., Kelly J.P., von Lueder T.G., et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 2014, 64:2281-2293.
59. Gustafsson F., Kragelund C.B., Torp-Pedersen C., et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 2005, 26:58-64.
60. Iversen K.K., Kjaergaard J., Akkan D., et al. Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med 2008, 264:361-369.
61. Edelmann F., Wachter R., Schmidt A.G., et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 2013, 309:781-791.
62. Hartley L.H., Flaker G., Basta L., et al. Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril. Am J Cardiol 1995, 76:857-860.
63. Gullestad L., Manhenke C., Aarsland T., et al. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure-a substudy to the MERIT-HF trial. Eur J Heart Fail 2001, 3:463-468.
64. Abdulla J., Burchardt H., Abildstrøm S.Z., et al. The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function. Eur Heart J 2003, 24:2116-2122. TRACE Study Group.
65. Dubach P., Myers J., Bonetti P., et al. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging. Am Heart J 2002, 143:676-683.
66. Guazzi M., Agostoni P., Matturri M., Pontone G., Guazzi M.D. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol. Am Heart J 1999, 138:460-467.
67. Waagstein F., Bristow M.R., Swedberg K., et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 1993, 342:1441-1446.
68. Krum H., Sackner-Bernstein J.D., Goldsmith R.L., et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995, 92:1499-1506.
69. Abdulla J., Kober L., Christensen E., Torp-Pedersen C. Effect of beta-blocker therapy on functional status in patients with heart failure-a meta-analysis. Eur J Heart Fail 2006, 8:522-531.
70. Packer M., Gheorghiade M., Young J.B., et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 1993, 329:1-7.
71. Sullivan M., Atwood J.E., Myers J., et al. Increased exercise capacity after digoxin administration in patients with heart failure. J Am Coll Cardiol 1989, 13:1138-1143.
72. Young J.B., Abraham W.T., Smith A.L., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003, 289:2685-2694.
73. Hermann T.S., Dall C.H., Christensen S.B., et al. Effect of high intensity exercise on peak oxygen uptake and endothelial function in long-term heart transplant recipients. Am J Transplant 2011, 11:536-541.
74. Jung M.H., Gustafsson F. Exercise in heart failure patients supported with a left ventricular assist device. J Heart Lung Transplant 2015, 34:489-496.
75. Brassard P., Jensen A.S., Nordsborg N., et al. Central and peripheral blood flow during exercise with a continuous-flow left ventricular assist device: constant versus increasing pump speed: a pilot study. Circ Heart Fail 2011, 4:554-560.
76. Jung M.H., Hansen P.B., Sander K., et al. Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study. Eur J Heart Fail 2014, 16:403-408.
77. O'Connor C.M., Whellan D.J., Lee K.L., et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009, 301:1439-1450.
78. Ismail H., McFarlane J.R., Dieberg G., Smart N.A. Exercise training program characteristics and magnitude of change in functional capacity of heart failure patients. Int J Cardiol 2014, 171:62-65.
79. Haykowsky M.J., Timmons M.P., Kruger C., et al. Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions. Am J Cardiol 2013, 111:1466-1469.
80. Hambrecht R., Hilbrich L., Erbs S., et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000, 35:706-713.
81. Siegel G. Basic Neurochemistry: Molecular, Cellular and Medical Aspects 1999, Lippincott Williams & Wilkins, Philadelphia, PA. 6th ed.
82. Cipolla M. Control of cerebral blood flow. The Cerebral Circulation 2009, Morgan and Claypool Life Sciences, San Rafael, CA.
83. Willie C.K., Tzeng Y.C., Fisher J.A., Ainslie P.N. Integrative regulation of human brain blood flow. J Physiol 2014, 592:841-859.
84. Ogoh S., Ainslie P.N. Regulatory mechanisms of cerebral blood flow during exercise: new concepts. Exerc Sport Sci Rev 2009, 37:123-129.
85. Scheinberg P., Blackburn L.I., Rich M., Saslaw M. Effects of vigorous physical exercise on cerebral circulation and metabolism. Am J Med 1954, 16:549-554.
86. Zobl E.G., Talmers F.N., Christensen R.C., Baer L.J. Effect of exercise on the cerebral circulation and metabolism. J Appl Physiol 1965, 20:1289-1293.
87. Subudhi A.W., Lorenz M.C., Fulco C.S., Roach R.C. Cerebrovascular responses to incremental exercise during hypobaric hypoxia: effect of oxygenation on maximal performance. Am J Physiol Heart Circ Physiol 2008, 294:H164-H171.
88. Smith K.J., Wong L.E., Eves N.D., et al. Regional cerebral blood flow distribution during exercise: influence of oxygen. Respir Physiol Neurobiol 2012, 184:97-105.
89. Brugniaux J.V., Marley C.J., Hodson D.A., New K.J., Bailey D.M. Acute exercise stress reveals cerebrovascular benefits associated with moderate gains in cardiorespiratory fitness. J Cereb Blood Flow Metab 2014, 34:1873-1876.
90. Secher N.H., Seifert T., Van Lieshout J.J. Cerebral blood flow and metabolism during exercise: implications for fatigue. J Appl Physiol 2008, 104:306-314.
91. Querido J.S., Sheel A.W. Regulation of cerebral blood flow during exercise. Sports Med 2007, 37:765-782.
92. Faraci F.M. Protecting the brain with eNOS: run for your life. Circ Res 2006, 99:1029-1030.
93. Bolduc V., Thorin-Trescases N., Thorin E. Endothelium-dependent control of cerebrovascular functions through age: exercise for healthy cerebrovascular aging. Am J Physiol Heart Circ Physiol 2013, 305:H620-H633.
94. Brassard P., Seifert T., Wissenberg M., et al. Phenylephrine decreases frontal lobe oxygenation at rest but not during moderately intense exercise. J Appl Physiol 2010, 108:1472-1478.
95. Olin J.T., Dimmen A.C., Subudhi A.W., Roach R.C. Cerebral blood flow and oxygenation at maximal exercise: the effect of clamping carbon dioxide. Respir Physiol Neurobiol 2010, 175:176-180.
96. Sato K., Sadamoto T., Ueda-Sasahara C., et al. Central command and the increase in middle cerebral artery blood flow velocity during static arm exercise in women. Exp Physiol 2009, 94:1132-1138.
97. Lautenschlager N.T., Cox K., Cyarto E.V. The influence of exercise on brain aging and dementia. Biochim Biophys Acta 2012, 1822:474-481.
98. Ainslie P.N., Cotter J.D., George K.P., et al. Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human ageing. J Physiol 2008, 586:4005-4010.
99. Bailey D.M., Marley C.J., Brugniaux J.V., et al. Elevated aerobic fitness sustained throughout the adult lifespan is associated with improved cerebral hemodynamics. Stroke 2013, 44:3235-3238.
100. Koike A., Itoh H., Oohara R., et al. Cerebral oxygenation during exercise in cardiac patients. Chest 2004, 125:182-190.
101. Myers J., Salleh A., Buchanan N., et al. Ventilatory mechanisms of exercise intolerance in chronic heart failure. Am Heart J 1992, 124:710-719.
102. Piepoli M.F., Guazzi M., Boriani G., et al. Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. Eur J Cardiovasc Prev Rehabil 2010, 17:637-642.
103. Cassaglia P.A., Griffiths R.I., Walker A.M. Sympathetic nerve activity in the superior cervical ganglia increases in response to imposed increases in arterial pressure. Am J Physiol Regul Integr Comp Physiol 2008, 294:R1255-R1261.
104. Tzeng Y.C., Willie C.K., Atkinson G., et al. Cerebrovascular regulation during transient hypotension and hypertension in humans. Hypertension 2010, 56:268-273.
105. Kumai Y., Ooboshi H., Ago T., et al. Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure. Exp Neurol 2008, 210:441-448.
106. Gelmers H.J. Effect of calcium antagonists on the cerebral circulation. Am J Cardiol 1987, 59:173B-176B.
107. Madsen P.L., Vorstrup S., Schmidt J.F., Paulson O.B. Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers. Eur J Clin Pharmacol 1990, 39:295-297.
108. Heinke W., Zysset S., Hund-Georgiadis M., Olthoff D., von Cramon D.Y. The effect of esmolol on cerebral blood flow, cerebral vasoreactivity, and cognitive performance: a functional magnetic resonance imaging study. Anesthesiology 2005, 102:41-50.
109. Seifert T., Rasmussen P., Secher N.H., Nielsen H.B. Cerebral oxygenation decreases during exercise in humans with beta-adrenergic blockade. Acta Physiol (Oxf) 2009, 196:295-302.
110. Ide K., Boushel R., Sorensen H.M., et al. Middle cerebral artery blood velocity during exercise with beta-1 adrenergic and unilateral stellate ganglion blockade in humans. Acta Physiol Scand 2000, 170:33-38.
111. Traub Y.M., Shapiro A.P., Dujovny M., Nelson D. Cerebral blood flow changes with diuretic therapy in elderly subjects with systolic hypertension. Clin Exp Hypertens 1982, 4:1193-1201.
112. Ono M., Joshi B., Brady K., et al. Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation. J Cardiothorac Vasc Anesth 2012, 26:1022-1028.
113. Bellapart J., Chan G.S., Tzeng Y.C., et al. The effect of ventricular assist devices on cerebral autoregulation: a preliminary study. BMC Anesthesiol 2011, 11:4.
114. Cornwell W.K., Tarumi T., Aengevaeren V.L., et al. Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices. J Heart Lung Transplant 2014, 33:1295-1303.
115. Massaro A.R., Dutra A.P., Almeida D.R., Diniz R.V., Malheiros S.M. Transcranial Doppler assessment of cerebral blood flow: effect of cardiac transplantation. Neurology 2006, 66:124-126.
116. Smirl J.D., Haykowsky M.J., Nelson M.D., Altamirano-Diaz L.A., Ainslie P.N. Resting and exercise cerebral blood flow in long-term heart transplant recipients. J Heart Lung Transplant 2012, 31:906-908.
117. Smirl J.D., Haykowsky M.J., Nelson M.D., et al. Relationship between cerebral blood flow and blood pressure in long-term heart transplant recipients. Hypertension 2014, 64:1314-1320.
118. Gayda M., Desjardins A., Lapierre G., etal Cerebral hemodynamics during exercise and recovery in heart transplant recipients. Can J Cardiol 2016, 32:539-546.
119. Fu T.C., Wang C.H., Lin P.S., et al. Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure. Int J Cardiol 2013, 167:41-50.
120. Fu T.C., Yang N.I., Wang C.H., et al. Aerobic interval training elicits different hemodynamic adaptations between heart failure patients with preserved and reduced ejection fraction. Am J Phys Med Rehabil 2016, 95:15-27.
121. Ogoh S., Brothers R.M., Barnes Q., et al. The effect of changes in cardiac output on middle cerebral artery mean blood velocity at rest and during exercise. J Physiol 2005, 569:697-704.
122. Murrell C.J., Cotter J.D., Thomas K.N., et al. Cerebral blood flow and cerebrovascular reactivity at rest and during sub-maximal exercise: effect of age and 12-week exercise training. Age (Dordr) 2013, 35:905-920.
123. Imray C.H., Myers S.D., Pattinson K.T., et al. Effect of exercise on cerebral perfusion in humans at high altitude. J Appl Physiol 2005, 99:699-706.
124. Subudhi A.W., Dimmen A.C., Roach R.C. Effects of acute hypoxia on cerebral and muscle oxygenation during incremental exercise. J Appl Physiol 2007, 103:177-183.
125. Subudhi A.W., Miramon B.R., Granger M.E., Roach R.C. Frontal and motor cortex oxygenation during maximal exercise in normoxia and hypoxia. J Appl Physiol 2009, 106:1153-1158.
126. Rasmussen P., Stie H., Nielsen B., Nybo L. Enhanced cerebral CO2 reactivity during strenuous exercise in man. Eur J Appl Physiol 2006, 96:299-304.
127. Subudhi A.W., Olin J.T., Dimmen A.C., et al. Does cerebral oxygen delivery limit incremental exercise performance?. J Appl Physiol 2011, 111:1727-1734.
128. Siebenmann C., Sorensen H., Jacobs R.A., et al. Hypocapnia during hypoxic exercise and its impact on cerebral oxygenation, ventilation and maximal whole body O(2) uptake. Respir Physiol Neurobiol 2013, 185:461-467.
129. Fan J.L., Bourdillon N., Kayser B. Effect of end-tidal CO2 clamping on cerebrovascular function, oxygenation, and performance during 15-km time trial cycling in severe normobaric hypoxia: the role of cerebral O2 delivery. Physiol Rep 2013, 1:e00066.
130. Oliveira M.F., Alencar M.C., Arbex F., et al. Effects of heart failure on cerebral blood flow in COPD: rest and exercise. Respir Physiol Neurobiol 2015, 221:41-48.
131. Gonzalez-Alonso J., Dalsgaard M.K., Osada T., et al. Brain and central haemodynamics and oxygenation during maximal exercise in humans. J Physiol 2004, 557:331-342.
132. Rasmussen P., Nielsen J., Overgaard M., et al. Reduced muscle activation during exercise related to brain oxygenation and metabolism in humans. J Physiol 2010, 588:1985-1995.
133. Willie C.K., Colino F.L., Bailey D.M., et al. Utility of transcranial Doppler ultrasound for the integrative assessment of cerebrovascular function. J Neurosci Methods 2011, 196:221-237.
134. Sato K., Fisher J.P., Seifert T., et al. Blood flow in internal carotid and vertebral arteries during orthostatic stress. Exp Physiol 2012, 97:1272-1280.
135. Haubrich C., Wendt A., Diehl R.R., Klotzsch C. Dynamic autoregulation testing in the posterior cerebral artery. Stroke 2004, 35:848-852.
136. Sato K., Sadamoto T., Hirasawa A., et al. Differential blood flow responses to CO2 in human internal and external carotid and vertebral arteries. J Physiol 2012, 590:3277-3290.
137. Sato K., Ogoh S., Hirasawa A., Oue A., Sadamoto T. The distribution of blood flow in the carotid and vertebral arteries during dynamic exercise in humans. J Physiol 2011, 589:2847-2856.